Rechercher les résultats

• Terminé

  GH16-005, LESOTHO, PROVIDE MINER-FRIENDLY SERVICES FOR INTEGRATED TB/HIV CARE (PROMISE)

  Howard, A. A. (PI)

  Centers for Disease Control and Prevention, Center for Global Health

  9/30/16 → 9/29/21

  Projet

  • Human Immunodeficiency Virus 100%
  • Lesotho 100%
  • Prophylaxis 18%
  • Isoniazid 18%
  • Implementation Science 11%

• GH16-005, LESOTHO, PROVIDE MINER-FRIENDLY SERVICES FOR INTEGRATED TB/HIV CARE (PROMISE)

  Howard, A. A. (PI)

  Centers for Disease Control and Prevention, Center for Global Health

  9/30/16 → 9/29/21

  Projet

  • Human Immunodeficiency Virus 100%
  • Lesotho 100%
  • Prophylaxis 18%
  • Isoniazid 18%
  • Implementation Science 11%

• GH16-005, LESOTHO, PROVIDE MINER-FRIENDLY SERVICES FOR INTEGRATED TB/HIV CARE (PROMISE)

  Howard, A. A. (PI)

  Centers for Disease Control and Prevention

  9/30/16 → 9/29/21

  Projet

• GH16-005, LESOTHO, PROVIDE MINER-FRIENDLY SERVICES FOR INTEGRATED TB/HIV CARE (PROMISE)

  Howard, A. A. (PI)

  Centers for Disease Control and Prevention, Center for Global Health

  9/30/16 → 9/29/21

  Projet

  • Human Immunodeficiency Virus 100%
  • Lesotho 100%
  • Prophylaxis 18%
  • Isoniazid 18%
  • Implementation Science 11%

• GH16-005, LESOTHO, PROVIDE MINER-FRIENDLY SERVICES FOR INTEGRATED TB/HIV CARE (PROMISE)

  Howard, A. A. (PI)

  Centers for Disease Control and Prevention, Center for Global Health

  9/30/16 → 9/29/18

  Projet

  • Human Immunodeficiency Virus 100%
  • Lesotho 100%
  • Prophylaxis 18%
  • Isoniazid 18%
  • Implementation Science 11%

• GH15-1583, SWAZILAND: STRENGTHENING LOCAL CAPACITY TO DELIVER SUSTAINABLE QUALITY-ASSURED UNIVERSAL COVERAGE OF CLINICAL HIV/TB SERVICES

  Howard, A. A. (PI)

  Centers for Disease Control and Prevention, Center for Global Health

  4/1/15 → 3/31/20

  Projet

• GH15-1583, SWAZILAND: STRENGTHENING LOCAL CAPACITY TO DELIVER SUSTAINABLE QUALITY-ASSURED UNIVERSAL COVERAGE OF CLINICAL HIV/TB SERVICES

  Howard, A. A. (PI)

  Centers for Disease Control and Prevention, Center for Global Health

  4/1/15 → 3/31/20

  Projet

• Global HIV Implementation Science Research Training Grant Renewal

  Howard, A. A. (PI)

  National Institute of Allergy and Infectious Diseases

  9/1/14 → 8/31/20

  Projet

  • Research Training 100%
  • Implementation Science 100%
  • Human Immunodeficiency Virus 100%
  • Healthcare 80%
  • Translational Research 80%

• A Combination Intervention Package for Isoniazid Preventive Therapy in Ethiopia

  Howard, A. A. (PI)

  National Institute of Allergy and Infectious Diseases

  6/20/12 → 2/28/17

  Projet

  • Prophylaxis 100%
  • Isoniazid 100%
  • Human Immunodeficiency Virus 85%
  • Health Care Quality 32%
  • Patient Compliance 16%

• PS09-930, STRENGTHENING TB/HIV COLLABORATION IN THE KINGDOM OF LESOTHO

  Howard, A. A. (PI)

  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

  9/30/09 → 6/30/15

  Projet

• STRENGTHENING TB/HIV COLLABORATION IN THE KINGDOM OF LESOTHO UNDER PEPFAR

  Howard, A. A. (PI)

  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

  9/30/09 → 9/29/14

  Projet

• PS09-930: STRENGTHENING TB/HIV COLLABORATION IN THE KINGDOM OF LESOTHO (PEPFAR)

  Howard, A. A. (PI)

  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

  9/30/09 → 9/29/14

  Projet

• PS09-930, STRENGTHENING TB/HIV COLLABORATION IN THE KINGDOM OF LESOTHO

  Howard, A. A. (PI)

  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

  9/30/09 → 6/30/15

  Projet

• HEP-C PILOT

  Howard, A. A. (PI)

  National Center for Research Resources

  2/15/07 → 11/30/07

  Projet

• HEPC

  Howard, A. A. (PI)

  2/15/07 → 11/30/07

  Projet

  • Infection 100%
  • Hepatitis C 100%
  • Medical Record 50%
  • Insulin Level 50%
  • Non Insulin Dependent Diabetes Mellitus 50%

• HEPC

  Howard, A. A. (PI)

  National Center for Research Resources

  12/1/05 → 11/30/06

  Projet

• Impaired Glucose Metabolism in HIV-Infected Drug Users

  Howard, A. A. (PI)

  National Institute on Drug Abuse

  2/1/03 → 1/31/08

  Projet

  • Human Immunodeficiency Virus 100%
  • Glucose Metabolism 100%
  • Drug Use 100%
  • Hepatitis C 100%
  • HIV 100%

• GENERAL CLINICAL RESEARCH CENTER M01 RR12248

  Spiegel, A. (PI), Purpura, D. (CoPI), Spiegel, A. A. M. (CoPI), Howard, A. A. (CoPI), Melman, A. A. (CoPI), Bloom, B. B. R. (CoPI), Diamond, B. B. (CoPI), Segal-isaacson, C. C. (CoPI), Stein, D. D. C. (CoPI), Schoenbaum, E. E. E. (CoPI), Kaskel, F. F. (CoPI), Ho, G. G. Y. (CoPI), Shamoon, H. H. (CoPI), Hetherington, H. H. P. (CoPI), Crystal, H. H. (CoPI), Roy-chowdhury, J. J. (CoPI), Pollard, J. J. W. (CoPI), Rieder, J. J. (CoPI), Crandall, J. J. P. (CoPI), Wylie-rosett, J. J. (CoPI), Pan, J. J. W. (CoPI), Rossetti, L. L. (CoPI), Weiss, L. L. M. (CoPI), Bigal, M. M. (CoPI), Hawkins, M. M. A. (CoPI), Brownlee, M. M. A. (CoPI), Alderman, M. M. H. (CoPI), Schilsky, M. M. L. (CoPI), Fabry, M. M. E. (CoPI), Roy-chowdhury, N. N. (CoPI), Barzilai, N. N. J. (CoPI), Fleischer, N. N. S. (CoPI), Santoro, N. N. F. (CoPI), Kennan, R. R. P. (CoPI), Bookchin, R. R. M. (CoPI), Klein, R. R. M. (CoPI), Lipton, R. R. B. (CoPI), Burk, R. R. D. (CoPI), Nagel, R. R. L. (CoPI), Engel, S. S. S. (CoPI), Gupta, S. S. (CoPI), Somlo, S. S. (CoPI), Berk, S. S. (CoPI), Weber, T. T. J. (CoPI), Frishman, W. W. H. (CoPI), Noyer, C. C. (CoPI), Barzilai, N. J. (CoPI), Burk, R. D. (CoPI), Fabry, M. E. (CoPI), Fleischer, N. S. (CoPI), Hawkins, M. A. (CoPI), Ho, G. Y. (CoPI), Kaufman, H. L. (CoPI), Nagel, R. L. (CoPI), Rubenstein, A. (CoPI), Santoro, N. F. (CoPI), Schilsky, M. L. (CoPI), Stein, D. T. (CoPI), Wadler, S. H. (CoPI) & Wozniak, R. (CoPI)

  9/30/97 → 11/30/97

  Projet

  • Clinical Research 100%
  • Program Director 60%
  • Doctor of Philosophy 60%
  • Medicine 40%
  • Outpatient 40%